Feline Toxoplasmosis: Pathogenesis, Neurological Manifestations, Zoonotic Risk, and Prevention

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-06-06

Key Takeaways

• Toxoplasma gondii is an obligate intracellular parasite with felids as definitive hosts, where the sexual cycle occurs in the intestinal epithelium, leading to oocyst shedding. Cats acquire infection through ingestion of tissue cysts from intermediate hosts or sporulated oocysts from the environment.
• Neurological manifestations in cats, often termed "feline toxoplasmosis brain," result from tachyzoite proliferation in the central nervous system, leading to signs such as seizures, ataxia, and altered behavior. Diagnosis involves serological tests (IgM/IgG), cerebrospinal fluid analysis, and PCR detection of parasite DNA.
• Oocyst shedding in cat feces is the primary route of environmental contamination, with oocysts remaining infective for months. Ingestion by humans, particularly pregnant women and immunocompromised individuals, poses a significant zoonotic risk, potentially leading to congenital transmission or severe illness.
• Prevention strategies include confining cats indoors, feeding cooked diets, daily litter box cleaning (oocysts require 1-5 days to sporulate), and meticulous hygiene to avoid fecal-oral transmission.
• Diagnostic advancements include sensitive and specific colloidal gold immunochromatographic strips for antibody detection and antisense PCR assays for improved parasite DNA detection in feline tissues.
• Treatment for clinical toxoplasmosis in cats typically involves clindamycin, pyrimethamine, and sulfadiazine, with clindamycin being crucial for CNS penetration. Gene-edited and mRNA vaccines are promising future control measures, though not yet widely available.

Introduction

Toxoplasma gondii is an obligate intracellular apicomplexan parasite that infects a broad range of warm-blooded vertebrates [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. Felids, both domestic and wild, serve as the definitive hosts in which the sexual phase of the life cycle occurs [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>]. Infection in cats is typically subclinical but can cause overt disease, particularly neurological and ocular manifestations [<a href="#ref-5">5</a>]. The parasite is also a major zoonotic pathogen, with oocyst shedding in cat feces representing a primary environmental contamination route [<a href="#ref-6">6</a>, <a href="#ref-7">7</a>]. This article provides a detailed examination of the pathogenesis, neurological involvement, zoonotic transmission, and prevention of feline toxoplasmosis, drawing exclusively on a curated set of recent peer-reviewed studies.

Etiology and Life Cycle

T. gondii exists in three infectious stages: tachyzoites, bradyzoites (within tissue cysts), and sporozoites (within oocysts) [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>]. The sexual cycle is restricted to the feline intestinal epithelium, where merozoites undergo gametogony and fertilization to produce unsporulated oocysts [<a href="#ref-4">4</a>, <a href="#ref-8">8</a>]. A single-cell atlas of sexual development in the feline gut has revealed previously uncharacterized transcriptional programs driving this process [<a href="#ref-4">4</a>]. After excretion, oocysts sporulate in the environment and become infective [<a href="#ref-6">6</a>]. Pre-sexual stages exhibit distinct cell division patterns, characterized by endopolygeny and asynchronous nuclear division [<a href="#ref-3">3</a>]. Domestic cats acquire infection by ingesting tissue cysts from intermediate hosts (e.g., rodents, birds) or by ingesting sporulated oocysts from contaminated soil or water [<a href="#ref-2">2</a>, <a href="#ref-7">7</a>].

Epidemiology

Seroprevalence of T. gondii in cats varies geographically. Studies in Hong Kong reported seroprevalence rates of 25.1% in privately owned cats and 38.4% in community cats, with risk factors including age and outdoor access [<a href="#ref-2">2</a>]. In Jordan, seroprevalence reached 41.3%, with molecular detection of parasite DNA in feces confirming active shedding [<a href="#ref-7">7</a>]. In Bangladesh, genotype distribution analysis showed a predominance of type II and III strains in domestic animals, including cats [<a href="#ref-9">9</a>]. Wildlife also is a sentinel for environmental contamination; nonhuman primates and wild felids in Brazilian zoos exhibited seropositivity rates exceeding 60% [<a href="#ref-10">10</a>]. A systematic review of T. gondii in Chinese wildlife (1985-2024) identified 77 species as intermediate hosts, emphasizing the broad zoonotic reservoir [<a href="#ref-11">11</a>]. Livestock such as goats, sheep, and cattle frequently exhibit high seroprevalence, particularly in regions with free‑ranging cats [<a href="#ref-12">12</a>, <a href="#ref-13">13</a>, <a href="#ref-14">14</a>]. Aborted fetuses in goats and horses have yielded PCR‑positive results, linking infection to reproductive failure [<a href="#ref-13">13</a>, <a href="#ref-15">15</a>]. Migratory birds also carry the parasite and may disseminate oocysts over long distances [<a href="#ref-16">16</a>].

Pathogenesis and Neurological Manifestations (Cat Toxoplasmosis Brain)

After ingestion, T. gondii crosses the intestinal epithelial barrier and disseminates hematogenously [<a href="#ref-8">8</a>]. The parasite preferentially invades neural and muscle tissues, forming latent bradyzoite cysts [<a href="#ref-5">5</a>, <a href="#ref-17">17</a>]. Reactivation in immunocompromised cats leads to tachyzoite proliferation and focal encephalitis [<a href="#ref-17">17</a>]. The term “cat toxoplasmosis brain” refers to cerebral inflammation caused by active tachyzoite replication in the central nervous system (CNS). Histopathological findings include multifocal gliosis, perivascular cuffing, and necrotic foci containing free tachyzoites and cysts [<a href="#ref-17">17</a>]. In a renal transplant recipient with cerebral toxoplasmosis, imaging revealed ring‑enhancing lesions in the basal ganglia [<a href="#ref-17">17</a>]; analogous pathology occurs in immunosuppressed cats. A population‑based cohort study in humans linked childhood T. gondii seropositivity to reduced grey matter volume and increased psychotic experiences, suggesting long‑lasting neuroanatomical effects [<a href="#ref-18">18</a>]. In cats, neurological signs include altered behavior, seizures, ataxia, head pressing, and cranial nerve deficits [<a href="#ref-5">5</a>, <a href="#ref-17">17</a>]. The microneme protein MIC17A has been identified as a promising marker for entero‑epithelial and chronic stages, facilitating detection of both acute and latent CNS infection [<a href="#ref-5">5</a>].

Neurological Manifestations in Feline Clinical Cases

Clinical toxoplasmosis in cats most frequently involves the CNS, eyes, or respiratory system [<a href="#ref-5">5</a>, <a href="#ref-7">7</a>]. Ocular presentations include anterior uveitis, chorioretinitis, and optic neuritis [<a href="#ref-19">19</a>, <a href="#ref-20">20</a>]. Neurological signs may result from both direct parasitic invasion and secondary inflammatory responses [<a href="#ref-17">17</a>, <a href="#ref-18">18</a>]. Diagnosis of cerebral toxoplasmosis relies on detection of anti‑T. gondii IgM/IgG in cerebrospinal fluid or identification of bradyzoites in brain biopsies [<a href="#ref-5">5</a>]. Anti‑sense PCR assays have shown high sensitivity for detecting T. gondii DNA in feline tissues, including brain [<a href="#ref-21">21</a>].

Zoonotic Risk and Oocyst Shedding (Toxoplasmosis in Cat Poop)

Toxoplasmosis in cat poop constitutes the primary source of environmental contamination [<a href="#ref-6">6</a>, <a href="#ref-7">7</a>]. A single cat can shed millions of oocysts over 1-2 weeks, and oocysts remain infective for months in moist soil [<a href="#ref-6">6</a>]. A study in Bangkok detected T. gondii DNA in 8.3% of fecal samples from stray cats, confirming ongoing environmental shedding [<a href="#ref-6">6</a>]. Seropositive cats from a neutering program in Brazil also harbored parasite DNA in reproductive tissues, suggesting a potential role for vertical transmission [<a href="#ref-22">22</a>]. Oocysts are resistant to many disinfectants and can be inadvertently ingested by intermediate hosts, including humans, through contaminated food or water [<a href="#ref-1">1</a>, <a href="#ref-12">12</a>]. In urban informal settlements in Brazil, social marginalization and environmental degradation were associated with higher T. gondii exposure [<a href="#ref-1">1</a>]. Veterinary professionals and students are at increased risk of seropositivity compared to the general population, underscoring occupational hazard [<a href="#ref-23">23</a>]. Pregnant women seronegative for toxoplasmosis are advised to avoid cleaning litter boxes; educational interventions in Côte d’Ivoire and Erbil have shown gaps in knowledge about transmission routes [<a href="#ref-24">24</a>, <a href="#ref-25">25</a>, <a href="#ref-26">26</a>]. Congenital transmission can occur if a woman acquires primary infection during pregnancy [<a href="#ref-26">26</a>, <a href="#ref-27">27</a>].

Diagnostic Approaches

Diagnosis of feline toxoplasmosis relies on serological, molecular, and histopathological methods. Serological detection of IgG and IgM antibodies is commonly performed using commercial ELISA kits or rapid immunochromatographic strips [<a href="#ref-28">28</a>, <a href="#ref-29">29</a>]. A double‑antigen sandwich colloidal gold strip developed for multiple host species showed high sensitivity and specificity for field use [<a href="#ref-28">28</a>]. A SAG1‑based strip specifically optimized for swine also demonstrated utility for cross‑species application [<a href="#ref-29">29</a>]. Molecular detection by conventional PCR or real‑time PCR targets the B1 gene or 529‑bp repeat element. Fecal PCR from stray cats in Thailand yielded a detection rate of 8.3% [<a href="#ref-6">6</a>]. An antisense PCR assay developed for domestic cats improved specificity by targeting complementary RNA transcripts [<a href="#ref-21">21</a>]. Histological examination of brain or muscle tissue can reveal cysts and tachyzoites, with immunohistochemistry confirming the presence of T. gondii antigen [<a href="#ref-13">13</a>]. The following table summarizes the main diagnostic modalities:

Treatment

Antiparasitic therapy is indicated for cats with clinical toxoplasmosis, particularly those exhibiting neurological or ocular signs. The combination of clindamycin (a lincosamide antibiotic) with pyrimethamine and sulfadiazine (a dihydrofolate reductase inhibitor plus sulfonamide) is the standard regimen. Clindamycin alone is effective for CNS disease due to its blood‑brain barrier penetration. Treatment duration typically extends for 2-4 weeks, and clinical improvement should be monitored. In immunocompromised cats, lifelong suppressive therapy may be required to prevent reactivation.

Prevention and Control

Prevention of feline toxoplasmosis targets both the cat as a source of oocyst shedding and the intermediate host (including humans) to reduce exposure. Management strategies include:

• Confining cats indoors to prevent hunting of infected prey [<a href="#ref-2">2</a>, <a href="#ref-7">7</a>].
• Feeding only cooked or commercial diets to avoid ingestion of tissue cysts [<a href="#ref-12">12</a>].
• Daily removal of feces from litter boxes, as oocysts require 1-5 days to sporulate and become infective [<a href="#ref-6">6</a>].
• Proper litter box hygiene: use gloves, wash hands thoroughly, and disinfect with ammonia or boiling water.
• Avoiding contamination of vegetable gardens and sandboxes with cat feces [<a href="#ref-1">1</a>, <a href="#ref-26">26</a>].

Vaccination is a promising avenue for long‑term control. Gene‑edited live‑attenuated vaccines have been developed by deleting key virulence genes (e.g., ROP18, MIC1), conferring protection against challenge in murine models [<a href="#ref-30">30</a>]. A review of antigen discovery strategies highlighted the potential of mRNA vaccines, particularly those targeting surface antigens SAG1 and SAG2, combined with One Health approaches [<a href="#ref-31">31</a>]. However, no licensed vaccine for cats is currently available in most countries.

One Health Perspectives

Given that T. gondii circulates among cats, wildlife, livestock, and humans, integrated control measures are essential [<a href="#ref-10">10</a>, <a href="#ref-12">12</a>, <a href="#ref-31">31</a>]. Educational campaigns targeting pregnant women and immunocompromised individuals have improved knowledge about zoonotic risks [<a href="#ref-24">24</a>, <a href="#ref-25">25</a>]. In addition, environmental monitoring of oocyst contamination in soil and water can inform public health interventions [<a href="#ref-1">1</a>, <a href="#ref-6">6</a>]. A Mermaid flowchart below summarizes the transmission pathways and intervention points.

flowchart TD
 A["Infected cat"] -->|"Oocysts in feces"| B["Environment: soil, water, litter box"]
 B -->|"Ingestion by intermediate host"| C["Rodents, birds, livestock"]
 C -->|"Tissue cysts"| D["Predation / raw diet"]
 D --> A
 B -->|"Ingestion by humans"| E["Zoonotic infection"]
 E --> F["Humans: pregnant, immunocompromised"]
 B -->|"Ingestion by cats"| A
 A -->|"Direct contact"| G["Veterinary professionals"]
 G -->|"Occupational exposure"| E
 style A fill:#f9f,stroke:#333,stroke-width:2px
 style E fill:#f96,stroke:#333,stroke-width:2px

Conclusion

Feline toxoplasmosis remains a significant concern for animal health and public health. The parasite’s ability to persist in neural tissues underlies a spectrum of neurological manifestations in cats, while oocyst shedding in feces perpetuates environmental contamination. Recent advances in molecular diagnostics, including antisense PCR and immunochromatographic strips, have improved detection sensitivity in field settings. Vaccine development using gene editing and mRNA platforms holds promise for reducing shedding in cats. A One Health approach integrating veterinary, environmental, and human health measures is essential to mitigate the zoonotic risk posed by T. gondii.

References

Related Clinical & Scientific Guides

• Tick-Borne Diseases in Dogs: Pathogens, Clinical Signs, Diagnosis, and Prevention
• Toxoplasmosis in Cats and the Risk of Brain Infection in Humans
• Dog Heartworm and Tick-Borne Disease Prevention